Adverse reactions to antiretroviral drugs in patients receiving therapy in a Federal teaching hospital Southwest Nigeria
No Thumbnail Available
Date
2014
Journal Title
Journal ISSN
Volume Title
Publisher
West African Journal of Pharmacy
Abstract
Background: Antiretroviral drugs have proven efficacy in reducing viral load to undetectable plasma levels.
Although, adverse reactions to antiretroviral drugs may cause death, prolongation of hospitalization, nonadherence
and treatment failure in HIV infected persons; they are not fully documented in Nigeria. It is
therefore necessary to evaluate adverse reactions of patients to antiretroviral drugs in Nigeria.
Objectives: This study aimed to document the adverse reactions to antiretroviral drugs (ARVs) in HIV-positive
patients, assess their severity causality and identify the risk factors for the development of the ADRs.
Methods: With the aid of data capture form and interview, information about ADR was obtained prospectively
from 51 new patients eligible to commence ARV for a period of 3 months. The retrospective arm made use of
information extracted from the case notes of 137 ARV-experienced patients selected using a web-based
random method from June 2009 – July 2010).
Results: Dizziness (17.40%) was the most frequently reported adverse event in both arms of the study followed
by body weakness (11.85%), anemia (11.11%), rash (9.63%), pruritus (9.63%), nausea and vomiting (7.41%)
and fatigue (7.41%). Majority of suspected ADRs were mild (76.5%) while only few were severe (3.9%). Female
+ 3 gender (p=0.0010), CD4 cells count below 200 cells/mm (p=0.0005) and antiretroviral drug combination of
Zidovudine + lamivudine + nevirapine (p=0.0099) were significantly associated with the development of ADRs
to ARVs.
Conclusion: The most common adverse event to antiretroviral drugs in this study was dizziness followed by
body weakness, anaemia, skin rash, body itching, lipodystrophy, nausea and vomiting. Most of the ADRs were
+ mild and their development was significantly associated with female gender, CD4 cells count below 200
3 cells/mm and antiretroviral drug combination of Zidovudine + lamivudine + nevirapine.
Description
Keywords
Adverse Drug Reactions, Antiretroviral therapy, HIV Patients